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Improved efficiency of plasmapheresis collection in Italy through licensed 
variations of current practice: a proposal
Giorgio Gandini
Department of Transfusion Medicine, Integrated University Hospital, Verona, Italy
Background. The overall production efficiency of plasmapheresis in Italy is significantly less 
than that indicated by international data, but can be significantly improved by slightly increasing 
the amount of plasma collected for each procedure, while fully respecting the current regulations. 
Materials and methods. In order to compare the average plasma volumes collected by means of 
apheresis in Italy and other European countries, we considered data supplied by Kedrion (the only 
company active in Italy in the field of plasma-derived products) relating to Italy and three centres 
managed by Kedrion in Germany. 
Results. In 2014, Kedrion received about 174,000 kg of plasma collected by means of 
plasmapheresis in Italy, for an average unit weight including anticoagulant of 577 g, as against the 
approximately 97,000 kg (average unit weight  including anticoagulant 783 g) produced by the three 
Kedrion centres in Germany.
The net weight of the plasma (without anticoagulant) contained in a plasmapheresis unit of 577 g is 
about 520 g, whereas a maximum collected volume of 600 mL (permitted by current Italian legislation 
without the need for volume reintegration) would provide a plasma unit volume of 660 mL (600 mL 
of plasma plus about 60 mL of anticoagulant): i.e. 14% more than that currently provided by Italian 
Transfusion Centres. This would increase the total amount of plasma sent to Kedrion to 199,500 kg, 
 without creating any major organisational difficulties (only a few minutes' increase in the length of 
the procedure) or additional costs, or increasing donor risk.
Discussion. It is possible to hypothesise the following donation volumes. Women weighing 
50-60 kg: 550 mL (net of anticoagulant), final unit volume about 610 mL; men, and women weighing 
>60 kg: 600 mL net, final unit volume about 660 mL. Using recently published data relating to the 
plasmapheresis centre in Verona (Italy), the cost of a litre of plasma is € 283.87 if the average unit 
volume (including anticoagulant) is 600 mL, and € 263.46 if it is 650 mL (i.e. a net plasma yield of 
585 mL): a 7.2% cost reduction simply by increasing final unit volume by 50 mL, something that is 
already feasible and perfectly safe, and does not require donor volume reintegration under current 
Italian law. 
Keywords: plasmapheresis, efficiency, regulations.
Introduction
Collecting plasma by means of plasmapherisis 
(PP) is critical in order to guarantee a sufficient supply 
of plasma-derived products (albumin, coagulation 
factors to integrate the use of recombinant factors) 
necessary for clinical use, with the aim of ensuring 
or at least approaching (e.g. in the case of aspecific 
immunoglobulins) regional and national self-sufficiency. 
Current data concerning the production of plasma by 
means of PP show that it is significantly less efficient 
in Italy than in other European and extra-European 
countries1-3. This is partially due to some ethical and 
regulatory limitations peculiar to Italy (first of all, 
the maximum quantity and maximum frequency of 
plasma donations are both clearly less than in other 
European countries, and the donations are voluntary 
and unremunerated), and specific historical choices 
concerning the way in which plasma collection 
(particularly by means of PP) is organised, which means 
that the plasma collection systems in Italy are generally 
under used.
Given these conditions, improving the efficiency of 
plasma donation while maintaining the principle of its 
gratuity and the public ownership of the donated blood 
components, requires making specific ethical, regulatory 
and organisational evaluations that are often long and 
complex, and cannot be rapidly applied. 
However, there is one aspect of donation by means 
of PP that can improve production efficiency without 
substantially affecting costs, without making any 
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organisational or regulatory changes, and without any 
giving rise to any additional donor risk. The question 
is whether it is possible to increase the per procedure 
collection of plasma in Italy, and by how much.
Materials and methods
In order to compare the average of plasma volumes 
collected by means of PP in Italy and other European 
countries, we considered data supplied by Kedrion 
(Kedrion SpA, Castelvecchio Pascoli, Italy) (the only 
company active in Italy in the field of plasma-derived 
products) relating to Italy and three centres managed 
by Kedrion in Germany. The per procedure efficiency 
of the collection was evaluated taking into account the 
Italian laws and regulations4,5, the Recommendations of 
the Council of Europe6, and the regulations applied at 
Kedrion's collection centres. 
It needs to be borne in mind that plasma collection 
in Italy is totally public and donors do not receive any 
direct remuneration, whereas the collection of plasma 
by means of PP in Germany is managed directly by 
the producers of plasma derivatives, and the donors' 
expenses are directly and immediately reimbursed (about 
€ 20/donation).
For the sake of simplicity, the volume and weight of 
plasma are considered equivalent.
Results
In 2014, Kedrion received about 198,000 kg of plasma 
collected by means of apheresis (PP and multicomponent 
apheresis) in Italy in accordance to national regulations, 
and regional or consortial contractual agreements. 
Considering the three major regional and inter-regional 
agreements, which cover about 90% of such plasma sent 
to Kedrion by Italian Transfusion Centres, the average 
weight of a bag of plasma (including anticoagulant) was 
560 g. Given that about 12% of the total amount plasma 
comes from multi-component collections (and therefore 
has an average unit weight of 400 g), the average weight 
of the plasma units obtained by means of PP (including 
anticoagulant) can be considered as being 577 g, and 
the overall amount of plasma obtained by means of PP 
about 174,500 kg.
The data from Kedrion's three plasma collection 
centres for the commercial production of plasma 
derivatives in Germany (Bayreuth, Fürth and Ingolstadt) 
indicate a total collection of 97,000 kg of plasma, for an 
average unit weight (including anticoagulant) of 783 g 
(Bayreuth 781, Fürth 793, and Ingolstadt 777 g).
Regulatory comparison
Current Italian regulations (particularly Ministerial 
Decree, 3 March 2005)4,5
The minimum interval between two plasma 
donations is 14 days, and the minimum amount of 
donatable plasma per session is 450 mL. The maximum 
donatable amount is 650 mL net of anticoagulant per 
session  (in the absence of volume reintegration, no 
more than 600 mL); 1.5 L per month, and 10 L per 
year. The maximum number of plasma donations per 
year is not explicitly stated, but is theoretically 26 (one 
every 14 days), although this is not possible because the 
maximum amount of plasma that can be donated per year 
is 10 L which, assuming 600 mL per PP session, would 
mean no more than 16-17 sessions. 
Forthcoming Italian regulations (Ministerial 
Decree in the course of publication)7 will not change 
the maximum number of plasma donations per year, 
the minimum interval between two donations, or the 
maximum amount of donatable plasma per month, but 
will change the minimum and maximum do natable amount 
per session (to respectively 600 mL and 700 mL net of 
anticoagulant), and the maximum donatable amount 
per year (12 L).
Rules at Kedrion's plasmapherisis centres in Germany 
Maximum number of plasma donations per year: 45; 
minimum interval between two donations: 48 hours; 
maximum donatable amount per session: 650 mL if 
body weight <60 kg, 750 mL if body weight 60-80 
kg, and 850 mL if body weight >80 kg; maximum 
donatable amount per year 38.25 L (equivalent to 
45 donations of 850 mL). Donations are directly 
reimbursed to donors. 
EDQM Recommendation R(95)15, 17th edition, 20136 
The per session volume collected (excluding 
anticoagulant) should never exceed 16% of estimated 
total blood volume, and never exceed 750 mL in the 
absence of fluid reintegration; the total blood volume 
of every donor should therefore be estimated before 
every donation. Furthermore, maximum extra-corporeal 
volume should never exceed 20%. The minimum 
interval between two donations should be 48 hours, 
and the maximum number of donations per year 33 
(equivalent to a maximum annual collected volume of 
24.75 L, assuming a maximum collected volume per 
session of 750 mL, net of anticoagulant).
It is clearly and ethically important that the primary 
objective of the regulations is donor safety, which is 
why they establish limits for the maximum amount 
of plasma that can be collected by means of PP per 
session and per year, and therefore a maximum annual 
number of sessions. However, it is also clear that, by 
excluding profit-making collection and any form of 
donor remuneration even in the case of "intensive" PP 
programmes (and therefore emphasising the ethical 
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nature of the donation and respect for the person of 
the donor), the Italian regulations establish much 
lower quantities and frequencies than the European 
regulations or the rules in force in countries where 
profit-making collection is allowed. On the other hand, 
what is of primary interest in terms of fractionation are 
the characteristics of the raw material, and therefore 
unit volumes and, even more, the real volume of plasma 
per unit.
Discussion
Current possibilities of improving efficiency in 
Italy, with reference to the Ministerial Decree of 3 
March 20055
It is possible to make some calculations. As the 
average unit weight of the plasma obtained by means 
of PP and sent to Kedrion is 577 g, the weight of the 
plasma net of anticoagulant is about 520 g (anticoagulant 
accounts for about 10% of the content). Reasoning in 
terms of net plasma volumes, and given a maximum 
volume of 600 mL (allowed by the current Italian 
regulations for both "occasional" and "intensive" PP 
sessions without requiring volume reintegration), it 
follows that a unit of plasma including anticoagulant 
could become 660 mL (600 mL di plasma + circa 60 
mL di anticoagulant): i.e. 14% more than the average 
sent to Kedrion.
Consequently, simply by modifying the amount 
donated per session, the same number of donations could 
increase the amount of plasma obtained by means of PP 
sent to Kedrion from 174,500 kg to 199,500 kg, without 
creating any major organisational difficulties (only a 
few minutes' increase in the length of the procedure) 
or additional costs, and without increasing donor risk. 
An additional 25,000 kg of  plasma would mean:
- at least 600,000 g of albumin (assuming a minimum 
yield of 24 g/L), equal to 60,000 50 mL vials of 
20% albumin; an economic value of € 1,800,000 
as calculated on the basis of the average purchase 
price of the marketed product (€ 3/g according to the 
ISTISAN 2012 Report)8;
- at least 87,500 g of immunoglobulins (assuming a 
minimum yield of 3.5 g/L), equal to 17,500 5 g vials; 
an economic value of €4,375,000 as calculated on the 
basis of the average purchase price of the marketed 
product (€ 50/g according to the ISTISAN 2012 
Report)8.
Respecting the current Italian regulations and without 
the need for donor volume reintegration, it is possible to 
hypothesise the following standard donation volumes:
- women weighing 50-60 kg: 550 mL net of anticoagulant, 
for a final unit volume of about 610 mL;
- women weighing >60 kg: 600 mL net of anticoagulant, 
for a final unit volume of about 660 mL;
- men: 600 mL net of anticoagulant, for a final unit 
volume of about 660 mL.
Possibility of further improvement in efficiency
It is also possible to make some hypotheses of 
improvements in per session efficiency by applying the 
European and forthcoming Italian regulations.
Applying EDQM Recommendation R(95)15, which 
indicates a collected volume (excluding anticoagulant) 
of no more than 16% of estimated total blood volume, 
and never more than 750 mL in the absence of volume 
reintegration, the following standard collected volumes 
could be obtained:
- woman weighing 50 kg and 160 cm tall (calculated 
blood volume 3,370 mL): 539 mL net of anticoagulant, 
for a final unit volume of about 600 mL;
- woman weighing 55 kg and 165 cm tall (calculated 
blood volume 3,586 mL) 574 mL net of anticoagulant, 
for a final unit volume of about 631 mL;
- men weighing 50 kg and 170 cm tall (calculated blood 
volume 3,981 mL): 637 mL net of anticoagulant, for 
a final unit volume of about 700 mL.
Applying the forthcoming Italian regulations, and 
with reference to R(95)15 without volume reintegration, 
the possible figures are:
- women weighing 50-60 kg: 600 mL  net of 
anticoagulant, for a final unit volume of about 
660 mL; 
- women weighing >60 kg: 650 mL net of anticoagulant, 
for a final unit volume of about 720 mL; 
- men weighing 50-60 kg: 650 mL net of anticoagulant, 
for a final unit volume of about 720 mL;
- men weighing >60 kg: 700 mL net of anticoagulant, 
for a final unit volume of about 770 mL. 
Using the plasma production costs at the Verona 
Department of Transfusion Medicine recently published 
by Eandi et al.1, the per litre cost of plasma obtained 
by means of PP is € 283.87 if the average unit volume 
(including anticoagulant) is 600 mL, and € 263.46 if it 
is 650 mL (i.e. a net plasma yield of 585 mL): a 7.2% 
cost reduction simply by increasing final unit volume by 
50 mL, something that is already feasible and perfectly 
safe, and does not require donor volume reintegration 
under current Italian law.
There are probably many reasons for which, in Italy, 
the amount of plasma collected from each individual 
plasmapheresis withdrawal procedure is significantly 
below the maximum approved level. But it is certainly 
the case that, when plasmapheresis programmes were 
started at the end of the 1980s/early 1990s, certain habits 
were formed that have since been proved to have had 
a strong influence on the way plasma is collected, and 
the collection procedures that have developed have 
never undergone critical revision. This, together with a 
All rights reserved - For personal use only 
No other uses without permission
© 
SIM
TI
 Se
rvi
zi 
Srl
s97
Blood Transfus 2016; 14 Suppl 2
Increasing plasmapheresis production efficiency
Correspondence: Giorgio Gandini
UOC Medicina Trasfusionale
Dipartimento Interaziendale di Medicina Trasfusionale della provincia di 
Verona - Azienda Ospedaliera Universitaria Integrata Verona
Piazzale Stefani 1
37126 Verona,  Italy
e-mail: giorgio.gandini@ospedaleuniverona.it
strong sense of respect for the donor, and in particular 
to women, may have led to an excessively cautious 
approach being adopted. 
This is in line with national legislation that imposes 
strict criteria to guarantee the maximum respect for 
donors and to ensure their safety.
Conclusions
It would really take little to improve the efficiency of 
collecting plasma by means of PP. Simply by  increasing 
the amount collected at each session, without making any 
changes in the current frequency of sessions or the total 
number of donations per year, and while fully respecting 
the health of the donor and the voluntary nature of the 
donations (no donor commitment to highly intensive 
programmes and no direct donor remuneration), the 
total annual amount of plasma could be increased by 
as much as 8-10% at no additional cost. And that is not 
to be disdained.
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